Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 23, 2019

SELL
$5.12 - $6.18 $185,108 - $223,431
-36,154 Closed
0 $0
Q4 2018

Feb 07, 2019

BUY
$4.68 - $6.25 $130,894 - $174,806
27,969 Added 341.71%
36,154 $181,000
Q3 2018

Oct 17, 2018

BUY
$5.15 - $6.3 $42,152 - $51,565
8,185 New
8,185 $51,000

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $332M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Ramsey Quantitative Systems Portfolio

Follow Ramsey Quantitative Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ramsey Quantitative Systems, based on Form 13F filings with the SEC.

News

Stay updated on Ramsey Quantitative Systems with notifications on news.